DCBLD2-ST3GAL6 Fusion FISH Probe
The DCBLD2-ST3GAL6 Fusion FISH Probe is used to confirm a fusion of the DCBLD2 and ST3GAL6 genes. The fusion of the DCBLD2 and ST3GAL6 genes has been associated with Lung Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| DCBLD2-ST3GAL6-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-RERE | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-REOR | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-REGO | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-REGR | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-OROR | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-GORE | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-GROR | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| DCBLD2-ST3GAL6-20-AQAQ | 20 (40 μL) | 200 μL |
|
ST3GAL6 Gene Summary
The protein encoded by this gene is a member of the sialyltransferase family. Members of this family are enzymes that transfer sialic acid from the activated cytidine 5'-monophospho-N-acetylneuraminic acid to terminal positions on sialylated glycolipids (gangliosides) or to the N- or O-linked sugar chains of glycoproteins. This protein has high specificity for neolactotetraosylceramide and neolactohexaosylceramide as glycolipid substrates and may contribute to the formation of selectin ligands and sialyl Lewis X, a carbohydrate important for cell-to-cell recognition and a blood group antigen. [provided by RefSeq, Apr 2016]
Gene Name: ST3 Beta-galactoside Alpha-2,3-sialyltransferase 6
Chromosome: CHR3: 98451571 -98513236
Locus: 3q12.1
DCBLD2 Gene Summary
The Discoidin, CUB And LCCL Domain Containing 2 (DCBLD2) gene is located on chr3 :98514813-98620533 at 3.
Gene Name: Discoidin, CUB And LCCL Domain Containing 2
Chromosome: CHR3: 98514813 -98620533
Locus: 3
Gene Diseases
The DCBLD2 ST3GAL6 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|